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The purpose of this paper is to present clinical and hemostatic studies on our patients with hereditary hemorrhagic disorders excluding the hemophilia group. Some additional observations concerning to the platelet thrombi formation in connection with hemostatic mechanism will be described.
I. Coagulation defects 1. Congenital deficiency of factor V (Parahemophilia) Congenital factor V deficiency is a very rare hemorrhagic disease.
Since Owren reported the first case with this disease in 1947, under the name of Parahemophilia, about 35 additional cases have been found in various parts of the world. Only two instances have been reported in Japan, including one by us which seemed to be the first case in this country.
The condition affects both males and females. Hemorrhagic tendency is noted in early life. Bleeding episode maybe manifested by nasal bleeding, easy bruisability, hemorrhage from gastrointestinal and urinary tracts, and excessive bleeding after dental extractions or surgical procedures. Except for the absence of hemarthrosis, these symptoms do not differ qualitatively from those of classic hemophilia.
The severity of bleeding varies from case to case, Profuse and prolonged menstruation has been reported, and one girl bled to death at the time of first menstrual period. Surprisingly, a delivery was not accompanied and followed by any unusual bleeding in whom menorrhagia were frequently observed.
Accordingly, the prognosis of this disease seemed to be reasonably good with regard to life. J. Med. 1963 
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B. 0. 33yrs. old, male. The platelet factor 1 activity was thus estimated, and it is proved that the platelet factor 1 activity of the patient's platelet was markedly reduced. Furthermore, the fact that the defect in platelet factor 1 was correctable by exposing the abnormal platelets to normal plasma was re-confirmed. From these observations we believe that the platelet factor 1 and factor V of plasma are closely related, and platelet factor 1 of platelets perhaps results from the adsorption of plasma factor V from plasma. The coexistence of deficiencies of factor VIII and factor V has been reported in four instances. The present case represents no such abnormality.
Two children had a prolonged one-stage prothrombin time and had a deficiency in foctor V. The exact mode of inheritance of parahemophilia is not clear. In this respect, the author's case seemed to supply a very valuable data.
2. Congenital deficiencies of the stable factors, factor VII and factor X In the 1940's, a number of patients, in whomthe one stage prothrombin time had been prolonged through life-long, were reported to have hereditary prothrombin deficiencies. In 1951, Alexander et al. found in a case the prolongation of prothrombin time was corrected by the addition of serum. Alexander assumed that the patient's plasma lacked some additional substance, and they named a such substance serum prothrombin conversion accelerator (SPCA). Since then, many cases have been described.
But the results of hemostatic studies revealed not uniform, and they seem to fall into two general groups, those which seem to coincide to Alexander's case of Factor VII deficiency and those which seem to have a defect described by Telfer and by
Hougie and Graham as deficiency of Factor X. factor and abnormal capillary walls, and has been designated as 'Vascular hemophilia'. Ever since the presence of vascular hemophilia was postulated, interpretation of these two diseases seemed to be in utter confusion.
Biggs et al. showed the evidence that some of their patients with von Willebrand's disease showed a moderate lack in factor VIII in the blood. Jiirgens re-examined the Aland Island bleeders, and discovered that their titer of factor VIII was often moderately low. Thus somo investigators have postulated the opinion that the hemorrhagic diathesis of Willebrand-Jurgens type and vascular hemophilia are the same disease. But other authorities stressed that so called "thrombopathia of Willebrand-Jurgens type", "vascular hemophilia", "angiohemophilia" and 41 pseudohemophilia" are varieties of the same disease, and classified into 5-8 different subgroups according to the laboratory data.
III. Defect in platelet

Thrombasthenia of Glanzmann
There is a rare disease which shows nearly the same hemorrhagic tendency as the thrombocytopenia inspite of the platelet count of the patient being normal. It is called "Glanzmann's thromb asthenia". And the defect seems to be transmitted as a dominant trait.
We have observed 5 typical cases of this disease. They are 38, "Vol. cytopenia. In any way, the thrombocytopenia in this degree never causes the hemorrhagic diathesis. In other patients, plalelet count disclosed normal or rather increased. There was no sign of platelet agglutination on the smeared film. And, furthermore, no clot retraction was observed. Also a prolonged bleeding time and a positive Rumpel-Leede phenomenon were demonstrated.
No abnormalities were found in various coagulation factors. As far as our studies concerned, the morphological abnormalities were found only under the electron microscope on ultrathin sectioned platelet samples. When the fibrin filament began to appear the fibrin net exhibits a radial formation adhering to the platelet conglomerates at their center in normal blood samples.
To the platelets of the thrombasthenia, however, most of fibrin filaments did not adhere. This looks as if there are some qualitative abnormalities in the patient's fibrin.. But the fibrin net produced by the recalcification of the patient's platelet-poor plasma containing normal platelets seemed to be quite normal.
Consequently, it may be concluded that the significant abnormality is present in the platelets of the patients. This finding has been firstly reported by Prof. Morita as the chracteristic and important abnormality found in this disease. We believe that the deficient adhesiveness of the patients' platelets to the fibrin induces a impaired clot retraction of the thrombasthenia.
Recently, some workers reported the change in ATPconcentration of the platelets during blood clotting. And some other investigators found a diminution of ATP level in the platelets of the thrombasthenia.
The author estimated the platelet ATP concentrationby the method of Cohn&Carter. In two cases of thrombasthenia, we found a uniform decline of ATPconcentration. But this diminution was rather slight than reported previously. By the present time, whether the diminution of ATP in platelets is the key to thrombasthenia and impaired clot retraction, is difficult to answer*.
